308sek
-4,9 %
Date:2024-04-26Time:17:29:36Latest report:Q1-2024List:First NorthTicker:ENZY
Market Cap:534 msekEnterprise Value:527 msekNet Sales:47,3 msekEarnings:-53,7 msekEmployees:0ISIN:SE0003943620
Ratios
10-year key figure history for Enzymatica turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Enzymatica with index and moving average MA50 and MA200.
Stockprice:3,08
MA50:3,26
MA200:3,37
Price/MA200:-8,6 %
RSI (14):39,9
Price/MA50:-5,6 %
Description
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.